Related Stories

• Scripps Announces Plans for Regions First Proton Therapy Center dollor 185 Million Facility to Offer Advanced Care to Cancer Patients
  
Scripps Health today announced plans to open the first patient care facility in San Diego County to offer advanced proton therapy to cancer patients. Groundbreaking for the $185 million ...
• Blocking gene boosts radiotherapy
  
A gene which hinders the ability of radiotherapy to kill cancer cells has been detected by UK researchers.
• Combinatorial therapy allows viruses to destroy tumors
  
For several years, researchers have been developing a new approach to treating cancer that uses viruses to infect and kill cancer cells while leaving normal cells unharmed. New research indicates ...
• Study shows phyical therapy exercise program can reduce risk of postnatal depression in new mothers
  
ALEXANDRIA, VA -- A physical therapy exercise and health education program is effective in improving postnatal well-being and reducing the risk for postnatal depression (PND), according to a... ...
• Combined drug therapy to treat TB and HIV significantly improves survival
  
Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which ...
• Gene based stem cell therapy specifically removes cell receptor that attracts HIV
  
UCLA AIDS Institute researchers successfully removed CCR5 -- a cell receptor to which HIV-1 binds for infection but which the human body does not need -- ...
• Nanotechnology tackles the two biggest problems associated with chemotherapy
  
Nanoscale chemistry experts have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, ...
• Phase II HIV gene therapy trial has encouraging results
  
In a new phase II study using gene therapy to combat HIV, seven of eight subjects experienced a decrease in viral load set point and one subject experienced prolonged, complete ...
• Short term heart disease risks of combination menopausal hormone therapy confirmed
  
New analyses from the Women's Health Initiative confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk ...
• Promising therapy for relapsing multiple sclerosis
  
Scientists have found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis.